← Every company
Alnylam Pharmaceuticals Inc SEC Filings
What Alnylam Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ALNY overview →Filings on file
128
since Nov 2, 2016
Warning signs
0
none filed
Last results
Jul 30, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 27, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 4, 2026 | Executive or director change 8-K | Read ↗ |
| Dec 3, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 18, 2025 | Executive or director change 8-K | Read ↗ |
| Mar 5, 2025 | Executive or director change 8-K | Read ↗ |
| Mar 4, 2024 | Executive or director change 8-K | Read ↗ |
| Jan 19, 2024 | Executive or director change 8-K | Read ↗ |
| Sep 28, 2023 | Executive or director change 8-K | Read ↗ |
| Aug 3, 2023 | Executive or director changeResults announced 8-K | Read ↗ |
| Mar 8, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 6, 2023 | Executive or director change 8-K | Read ↗ |
| Aug 24, 2022 | Executive or director change 8-K | Read ↗ |
| Apr 5, 2022 | Executive or director change 8-K | Read ↗ |
| Jan 4, 2022 | Executive or director change 8-K | Read ↗ |
| Dec 20, 2021 | Executive or director change 8-K | Read ↗ |
| Oct 28, 2021 | Executive or director changeResults announced 8-K | Read ↗ |
| Sep 8, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 3, 2021 | Executive or director changeResults announced 8-K | Read ↗ |
| Oct 2, 2020 | Executive or director changeMaterial agreement 8-K | Read ↗ |
| Aug 6, 2020 | Executive or director changeResults announced 8-K | Read ↗ |
| Feb 27, 2020 | Executive or director change 8-K | Read ↗ |
| Jul 11, 2019 | Executive or director change 8-K | Read ↗ |
| Oct 10, 2018 | Executive or director change 8-K | Read ↗ |
| May 15, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 14, 2018 | Executive or director change 8-K | Read ↗ |
| May 9, 2017 | Executive or director change 8-K | Read ↗ |
| Jan 3, 2017 | Executive or director change 8-K | Read ↗ |
Source: Alnylam Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ALNY
Company overviewEverything on ALNY in one place, with the price.Insider tradingWhat ALNY's own officers and directors buy and sell.Executive payWhat ALNY awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ALNY.Funds holding itWhich funds and ETFs hold ALNY, and how big a bet.LobbyingWhat ALNY spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ALNY's account, and who they worked for.PatentsWhat ALNY is filing at the patent office.